Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.066
+0.052 (5.13%)
Oct 13, 2026, 1:54 PM CET
Diamyd Medical AB Revenue
In the fiscal year ending August 31, 2026, Diamyd Medical AB had annual revenue of 4.68M SEK, down -6.62%. Diamyd Medical AB had revenue of 1.42M in the quarter ending August 31, 2026, with 65.69% growth. That makes Diamyd Medical AB the 46,572nd largest company in the world by revenue and 756th in Sweden.
Revenue
4.68M
Revenue Growth
-6.62%
P/S Ratio
329.46
Revenue / Employee
11.36K
Employees
42
Market Cap
165.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2026 | 4.68M | -332.00K | -6.62% |
| Aug 31, 2025 | 5.02M | 651.00K | 14.92% |
| Aug 31, 2024 | 4.36M | 617.00K | 16.47% |
| Aug 31, 2023 | 3.75M | 1.16M | 44.95% |
| Aug 31, 2022 | 2.59M | 2.14M | 482.21% |
| Aug 31, 2021 | 444.00K | -43.86M | -99.00% |
| Aug 31, 2020 | 44.30M | 42.66M | 2,606.11% |
| Aug 31, 2019 | 1.64M | 818.00K | 99.88% |
| Aug 31, 2018 | 819.00K | -216.00K | -20.87% |
| Aug 31, 2017 | 1.04M | -8.00K | -0.77% |
| Aug 31, 2016 | 1.04M | -169.00K | -13.94% |
| Aug 31, 2015 | 1.21M | 653.00K | 116.82% |
| Aug 31, 2014 | 559.00K | 394.00K | 238.79% |
| Aug 31, 2013 | 165.00K | -1.44M | -89.69% |
| Aug 31, 2012 | 1.60M | - | - |
| Aug 31, 2011 | - | - | - |
| Aug 31, 2010 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 129.48M |
| IRLAB Therapeutics AB | 79.33M |
| NextCell Pharma AB | 10.78M |
| Abera Bioscience AB | 9.10M |
| Elicera Therapeutics AB | 7.79M |
| OncoZenge AB | 5.97M |
| Xintela AB | 3.03M |
| Simris Group AB (PUBL) | 1.39M |
Diamyd Medical AB News
- 6 days ago - Diamyd Medical AB Quarterly report: Q4 2026 - Filings
- 3 months ago - Diamyd Medical AB Quarterly report: Q3 2026 - Filings
- 6 months ago - Diamyd Medical AB Transcript: Study result - Transcripts
- 6 months ago - Diamyd Medical AB Press release: Study result - Filings
- 6 months ago - Diamyd Medical AB Slides: Company presentation - Filings
- 6 months ago - Diamyd Medical AB Transcript: Q2 25/26 - Transcripts
- 6 months ago - Diamyd Medical AB Quarterly report: Q2 2026 - Filings
- 8 months ago - Diamyd Medical AB Transcript: Lilla Lördag - Transcripts